A citation-based method for searching scientific literature

Lincoln R Potter. FEBS J 2011
Times Cited: 203







List of co-cited articles
926 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
31


Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
395
13

Natriuretic peptides.
Lori B Daniels, Alan S Maisel. J Am Coll Cardiol 2007
711
13

A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
13

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
13

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
309
13

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
670
12

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
12

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
449
12


A Test in Context: Neprilysin: Function, Inhibition, and Biomarker.
Antoni Bayes-Genis, Jaume Barallat, A Mark Richards. J Am Coll Cardiol 2016
113
12

Structural substrate conditions required for neutral endopeptidase-mediated natriuretic Peptide degradation.
Kristin Pankow, Anja Schwiebs, Matthias Becker, Wolf-Eberhard Siems, Gerd Krause, Thomas Walther. J Mol Biol 2009
34
32

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
932
11


Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
328
11

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
156
10

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S Maisel, Padma Krishnaswamy, Richard M Nowak, James McCord, Judd E Hollander, Philippe Duc, Torbjørn Omland, Alan B Storrow, William T Abraham, Alan H B Wu,[...]. N Engl J Med 2002
10


Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
818
10

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
10

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
306
10

Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
141
9

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. J Clin Invest 2012
553
9


Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
Naohisa Tamura, Lynda K Doolittle, Robert E Hammer, John M Shelton, James A Richardson, David L Garbers. Proc Natl Acad Sci U S A 2004
201
9

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
Eric E Niederkofler, Urban A Kiernan, Jessica O'Rear, Santosh Menon, Syed Saghir, Andrew A Protter, Randall W Nelson, Ute Schellenberger. Circ Heart Fail 2008
132
8

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
296
8

Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
Nicolas Vodovar, Marie-France Séronde, Said Laribi, Etienne Gayat, Johan Lassus, James L Januzzi, Riadh Boukef, Semir Nouira, Philippe Manivet, Jane-Lise Samuel,[...]. JACC Heart Fail 2015
55
14

Natriuretic peptides in cardiovascular diseases: current use and perspectives.
Massimo Volpe, Speranza Rubattu, John Burnett. Eur Heart J 2014
151
8

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
679
8

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur,[...]. N Engl J Med 2000
696
8

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. Circulation 2017
8

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
226
8

Endothelial C-type natriuretic peptide maintains vascular homeostasis.
Amie J Moyes, Rayomand S Khambata, Inmaculada Villar, Kristen J Bubb, Reshma S Baliga, Natalie G Lumsden, Fang Xiao, Paul J Gane, Anne-Sophie Rebstock, Roberta J Worthington,[...]. J Clin Invest 2014
85
9

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye. Endocrinology 1992
652
8

Bioactivity and metabolism of C-type natriuretic peptide in normal man.
P J Hunt, A M Richards, E A Espiner, M G Nicholls, T G Yandle. J Clin Endocrinol Metab 1994
142
8

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
262
8

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Alan Maisel, Christian Mueller, Richard Nowak, W Frank Peacock, Judd W Landsberg, Piotr Ponikowski, Martin Mockel, Christopher Hogan, Alan H B Wu, Mark Richards,[...]. J Am Coll Cardiol 2010
352
7

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.
Alexander G Semenov, Alexander B Postnikov, Natalia N Tamm, Karina R Seferian, Natalia S Karpova, Marina N Bloshchitsyna, Ekaterina V Koshkina, Mihail I Krasnoselsky, Daria V Serebryanaya, Alexey G Katrukha. Clin Chem 2009
113
7

Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure.
Wayne L Miller, Mary A Phelps, Christina M Wood, Ute Schellenberger, Anh Van Le, Regis Perichon, Allan S Jaffe. Circ Heart Fail 2011
85
8

The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.
Massimo Volpe, Marino Carnovali, Vittoria Mastromarino. Clin Sci (Lond) 2016
117
7

Identification of amino-terminal pro-C-type natriuretic peptide in human plasma.
T C Prickett, T G Yandle, M G Nicholls, E A Espiner, A M Richards. Biochem Biophys Res Commun 2001
92
7

Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.
T G Yandle, A M Richards, M G Nicholls, R Cuneo, E A Espiner, J H Livesey. Life Sci 1986
274
7

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.
John B Kostis, Milton Packer, Henry R Black, Roland Schmieder, David Henry, Elliott Levy. Am J Hypertens 2004
354
7

Natriuretic peptides in cardiometabolic regulation and disease.
Nora E Zois, Emil D Bartels, Ingrid Hunter, Birgitte S Kousholt, Lisbeth H Olsen, Jens P Goetze. Nat Rev Cardiol 2014
103
7

NPR-C: a component of the natriuretic peptide family with implications in human diseases.
Speranza Rubattu, Sebastiano Sciarretta, Angelica Morriello, Camilla Calvieri, Allegra Battistoni, Massimo Volpe. J Mol Med (Berl) 2010
49
14

Cardiac fibrosis in mice lacking brain natriuretic peptide.
N Tamura, Y Ogawa, H Chusho, K Nakamura, K Nakao, M Suda, M Kasahara, R Hashimoto, G Katsuura, M Mukoyama,[...]. Proc Natl Acad Sci U S A 2000
431
7

Diverse biological actions of atrial natriuretic peptide.
B M Brenner, B J Ballermann, M E Gunning, M L Zeidel. Physiol Rev 1990
880
7

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.
P M Oliver, J E Fox, R Kim, H A Rockman, H S Kim, R L Reddick, K N Pandey, S L Milgram, O Smithies, N Maeda. Proc Natl Acad Sci U S A 1997
455
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.